WuXi Biologics (Cayman) Inc. (HKG:2269)
33.40
-0.08 (-0.24%)
Dec 12, 2025, 3:59 PM HKT
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
1.75M HKD
Profits / Employee
366.33K HKD
Market Cap
138.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12,575 | -165 | -1.30% |
| Dec 31, 2023 | 12,740 | 367 | 2.97% |
| Dec 31, 2022 | 12,373 | 2,509 | 25.44% |
| Dec 31, 2021 | 9,864 | 3,218 | 48.42% |
| Dec 31, 2020 | 6,646 | 980 | 17.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sino Biopharmaceutical | 24,379 |
| CSPC Pharmaceutical Group | 21,400 |
| BeOne Medicines AG | 11,000 |
| Hansoh Pharmaceutical Group Company | 8,989 |
| Innovent Biologics | 5,659 |
| 3SBio | 5,577 |
| JD Health International | 3,564 |
| Akeso | 3,035 |
WuXi Biologics News
- 10 days ago - WuXi Biologics Extends Global CRDMO Network to Qatar Through Strategic MoU Signed with Qatar Free Zones Authority - PRNewsWire
- 10 days ago - WuXi Biologics Signs MoU With Qatar Free Zones Authority To Set Up Middle East CRDMO Center - Nasdaq
- 7 weeks ago - WuXi Biologics Included in Hang Seng Corporate Sustainability Benchmark Index - PRNewsWire
- 7 weeks ago - WuXi Biologics Honored with 2025 Global Customer Value Leadership Recognition by Frost & Sullivan - PRNewsWire
- 2 months ago - WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year - PRNewsWire
- 2 months ago - WuXi Biologics Launches WuXia™4.0, Targeted Integration Cell Line Platform TrueSite TI™,to Accelerate Biologics Development with High Titer and Superior Stability - PRNewsWire
- 2 months ago - WuXi Biologics Selected as Constituent of FTSE4Good Index Series for Fifth Consecutive Year - PRNewsWire
- 3 months ago - Chinese biotechs get a shot in the arm from policy support, licensing deals - South China Morning Post